A detailed history of Gardner Lewis Asset Management L P transactions in Surmodics Inc stock. As of the latest transaction made, Gardner Lewis Asset Management L P holds 262,878 shares of SRDX stock, worth $8.13 Million. This represents 2.65% of its overall portfolio holdings.

Number of Shares
262,878
Previous 212,934 23.46%
Holding current value
$8.13 Million
Previous $8.26 Million 26.06%
% of portfolio
2.65%
Previous 2.34%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$37.5 - $40.13 $1.87 Million - $2 Million
49,944 Added 23.46%
262,878 $10.4 Million
Q3 2024

Nov 12, 2024

BUY
$38.47 - $42.24 $384,700 - $422,400
10,000 Added 4.93%
212,934 $8.26 Million
Q2 2024

Aug 12, 2024

BUY
$25.39 - $42.1 $5.15 Million - $8.54 Million
202,934 New
202,934 $8.53 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $433M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Gardner Lewis Asset Management L P Portfolio

Follow Gardner Lewis Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gardner Lewis Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Gardner Lewis Asset Management L P with notifications on news.